Astera Labs, Inc. (ALAB)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $35.37B
Last updated: Nov 17, 2026 at 4:43 PM ET
Astera Labs, Inc. (ALAB) Statistics
Astera Labs (ALAB) has a market cap of $35.37B and an enterprise value of $35.16B. Revenue grew 115.24% over the last 12 months from the 12 months before. Its share count is up 4.00% from a year earlier.
Total Valuation
Enterprise value is 0.59% below the market cap, as cash exceeds debt.
| Market Cap | $35.37B |
|---|---|
| Enterprise Value | $35.16B |
| Latest price (Nov 17, 2026) | $202.34 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 22.6x and 17.6x.
| P/E Ratio | 75.8x |
|---|---|
| Forward P/E | 45.6x |
| P/S Ratio | 22.6x |
| Forward P/S | 17.4x |
| P/B Ratio | 17.6x |
| P/TBV Ratio | 18.5x |
| P/FCF Ratio | 102.2x |
| P/OCF Ratio | 81.0x |
| PEG Ratio | 3.0 |
Enterprise Valuation
Counting debt and cash, the company is valued at 85.9x EBITDA and 101.6x free cash flow.
| EV / Earnings | 76.2x |
|---|---|
| EV / Sales | 22.6x |
| EV / EBITDA | 85.9x |
| EV / FCF | 101.6x |
Price Statistics
The stock is up 40.06% over 52 weeks and trades 30.73% below its 50-day average.
| Beta (1Y) | 4.05 |
|---|---|
| 52-Week Change | +40.06% |
| 1-Month Change | -29.21% |
| 3-Month Change | -33.32% |
| 6-Month Change | -6.14% |
| Total Return (1Y) | +40.06% |
| Return vs SPY (1Y) | +33.47% |
| Max Drawdown (1Y) | -62.84% |
| Max Drawdown (3Y) | -63.69% |
| Sharpe Ratio (1Y) | 0.37 |
| Correlation with SPY (1Y) | 0.55 |
| 50-Day Average | $292.10 |
| 200-Day Average | $257.72 |
| 52-Week Range | $97.89 to $499.48 |
| RSI (14 Days) | 35.8 |
| Average Volume (20 Days) | 5.02M |
Financial Position
Current assets cover 8.03x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 8.03x |
|---|---|
| Quick Ratio | 7.20x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 23.07% and return on assets is 20.05% over the last 12 months.
| Return on Equity (ROE) | 23.07% |
|---|---|
| Return on Assets (ROA) | 20.05% |
| Asset Turnover | 0.84x |
| Inventory Turnover | 2.58x |
| Receivables Turnover | 6.53x |
| Cash Conversion Cycle | 130 days |
Scores
ALAB has an Altman Z-Score of 72.66, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 72.66 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $1.56B over the last 12 months.
| Revenue | $1.56B |
|---|---|
| Revenue Growth (YoY) | +115.24% |
| Gross Profit | $1.15B |
| Operating Income | $397.10M |
| Pretax Income | $447.18M |
| Net Income | $461.32M |
| Reported EPS (TTM) | $2.67 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 86.96% of the $2.30B in total assets.
| Cash and Equivalents | $209.40M |
|---|---|
| Total Debt | $0 |
| Net Cash | $209.40M |
| Net Cash Per Share | $1.20 |
| Working Capital | $1.71B |
| Shareholder Equity | $2.00B |
| Book Value Per Share | $11.48 |
| Tangible Book Value | $1.91B |
| Tangible Book Per Share | $10.96 |
| Total Assets | $2.30B |
| Total Liabilities | $300.87M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $92.05M of capital spending, operating cash flow left $344.69M of free cash flow.
| Operating Cash Flow | $436.74M |
|---|---|
| Capital Expenditures | $92.05M |
| Free Cash Flow | $344.69M |
| FCF Per Share | $1.99 |
| Depreciation and Amortization | $20.61M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 25.52%.
| Gross Margin | 73.89% |
|---|---|
| Operating Margin | 25.52% |
| Pretax Margin | 28.73% |
| Net Margin | 29.64% |
| FCF Margin | 22.15% |
Dividends and Yields
ALAB does not pay a dividend. Its free cash flow yield is 0.98%.
| Earnings Yield | 1.32% |
|---|---|
| FCF Yield | 0.98% |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
Peer Position
Against 11 similar companies, ALAB has the 2nd highest P/E.
P/E RatioPeer median 33.7x
P/S RatioPeer median 7.1x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +26.41%
| P/E Ratio | 75.8x vs 33.7x median |
|---|---|
| P/S Ratio | 22.6x vs 7.1x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +115.24% vs +26.41% median |
Analyst Forecast
Consensus estimates put revenue growth at 99.34% and EPS growth at 97.15% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +99.34% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +97.15% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ALAB
What is ALAB's market cap?
Astera Labs has a market cap of $35.37B. Its enterprise value, which adds debt and subtracts cash, is $35.16B.
What is ALAB's P/E ratio?
Astera Labs has a trailing P/E ratio of 75.8x and a forward P/E of 45.6x.
How many shares of ALAB are outstanding?
Astera Labs has 174.13M shares outstanding. The count is up 4.00% from a year earlier.
Does ALAB pay a dividend?
No. Astera Labs does not pay a dividend.
How much debt does ALAB have?
Astera Labs has $0 of total debt and $209.40M of cash and equivalents, a net cash position of $209.40M.
ALAB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors